We are live on ! Find out more
AVXL icon

Anavex Life Sciences

78 hedge funds and large institutions have $57.7M invested in Anavex Life Sciences in 2020 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 24 increasing their positions, 22 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

10% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 10

1% more funds holding

Funds holding: 7778 (+1)

9% more repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 22

0.71% more ownership

Funds ownership: 20.36%21.08% (+0.71%)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

2% less capital invested

Capital invested by funds: $58.8M → $57.7M (-$1.14M)

56% less call options, than puts

Call options by funds: $760K | Put options by funds: $1.72M

Holders
78
Holders Change
+1
Holders Change %
+1.3%
% of All Funds
1.57%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
11
Increased
24
Reduced
22
Closed
10
Calls
$760K
Puts
$1.72M
Net Calls
-$959K
Net Calls Change
+$1.27M

AVXL Hedge Fund Activity: Q3 2020 in Review

78 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Anavex Life Sciences (AVXL) for Q3 2020, worth a combined $57.7M — down 1.9% from $58.8M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new AVXL positions and 10 closed out — a net gain of 1 holder — while 24 added to existing stakes and 22 trimmed.

The largest buyer was Russell Investments Group, adding an estimated $1.19M. The largest seller was Invesco, exiting entirely with an estimated $654K sold.

  • 78 institutional investors held Anavex Life Sciences (AVXL) as of Q3 2020, up from 77 in Q2 2020.
  • Funds reported $57.7M of Anavex Life Sciences stock for Q3 2020, down 1.9% quarter-over-quarter.
  • 11 funds opened new Anavex Life Sciences positions in Q3 2020 and 10 closed out, a net change of +1 holder.
  • The largest Anavex Life Sciences buyer in Q3 2020 was Russell Investments Group, an estimated $1.19M added.
  • The largest Anavex Life Sciences seller in Q3 2020 was Invesco, an estimated $654K sold.

Based on aggregated 13F filings for Q3 2020.